Literature DB >> 24217276

Is cholesterol and amyloid-β stress induced CD147 expression a protective response? Evidence that extracellular cyclophilin a mediated neuroprotection is reliant on CD147.

Limbikani J Kanyenda1, Guiseppe Verdile2, Ralph Martins3, Bruno P Meloni4, Joanne Chieng5, Francis Mastaglia5, Simon M Laws6, Ryan S Anderton5, Sherif Boulos5.   

Abstract

The CD147 protein is a ubiquitous multifunctional membrane receptor. Expression of CD147, which is regulated by sterol carrier protein, reportedly modulates amyloid-β (Aβ), the neurotoxic peptide implicated in neuronal degeneration in Alzheimer's disease (AD). Given that high fat/cholesterol is linked to amyloid deposition in AD, we investigated if cholesterol and/or Aβ can alter CD147 expression in rat cortical neuronal cultures. Water-soluble cholesterol and Aβ42 dose-dependently increased CD147 protein expression, but reduced FL-AβPP protein expression. Cholesterol and Aβ42 treatment also increased lactate dehydrogenase release but to varying degrees. Upregulation of CD147 expression was probably mediated by oxidative stress, as H2O2 (3 μM) also induced CD147 protein expression in neuronal cultures. In light of these findings, we investigated if CD147 induction was cytoprotective, a compensatory response to injury, or alternatively, a cell death signal. To this end, we used recombinant adenovirus to overexpress human CD147 (in SH-SY5Y cells and primary cortical neurons), and pre-treated cultures with or without recombinant cyclophilin A (rCYPA) protein, prior to Aβ42 exposure. We showed that increased CD147 expression protected against Aβ42, only when rCYPA protein was added to neuronal cultures. Together, our findings reveal potentially important relationships between cholesterol loading, CD147 expression, Aβ toxicity, and the putative involvement of CYPA protein in neuroprotection in AD.

Entities:  

Keywords:  Alzheimer's disease; Aβ$_{42}$; CD147; cholesterol; cyclophilin A; neuroprotection

Mesh:

Substances:

Year:  2014        PMID: 24217276     DOI: 10.3233/JAD-131442

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

1.  Effect of a quality-controlled fermented nutraceutical on skin aging markers: An antioxidant-control, double-blind study.

Authors:  Giuseppe Bertuccelli; Nicola Zerbinati; Massimiliano Marcellino; Navalpur Shanmugam Nanda Kumar; Fang He; Vladimir Tsepakolenko; Joseph Cervi; Aldo Lorenzetti; Francesco Marotta
Journal:  Exp Ther Med       Date:  2016-01-20       Impact factor: 2.447

Review 2.  The biological function and clinical utilization of CD147 in human diseases: a review of the current scientific literature.

Authors:  Lijuan Xiong; Carl K Edwards; Lijun Zhou
Journal:  Int J Mol Sci       Date:  2014-09-29       Impact factor: 5.923

3.  Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.

Authors:  Bao-Qing Xu; Zhi-Guang Fu; Yao Meng; Xiao-Qing Wu; Bo Wu; Liang Xu; Jian-Li Jiang; Ling Li; Zhi-Nan Chen
Journal:  Oncotarget       Date:  2016-09-20

4.  Microglia are both a source and target of extracellular cyclophilin A.

Authors:  Gurkiran Kaur Flora; Ryan S Anderton; Bruno P Meloni; Gilles J Guillemin; Neville W Knuckey; Gabriella MacDougall; Vance Matthews; Sherif Boulos
Journal:  Heliyon       Date:  2019-09-03

Review 5.  Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology.

Authors:  Deidiane Elisa Ribeiro; Ágatha Oliveira-Giacomelli; Talita Glaser; Vanessa F Arnaud-Sampaio; Roberta Andrejew; Luiz Dieckmann; Juliana Baranova; Claudiana Lameu; Mariusz Z Ratajczak; Henning Ulrich
Journal:  Mol Psychiatry       Date:  2020-12-16       Impact factor: 13.437

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.